Literature DB >> 30521086

Predicting Progression to Mild Cognitive Impairment.

Ronald C Petersen1,2, Emily S Lundt2, Terry M Therneau2, Stephen D Weigand2, David S Knopman1, Michelle M Mielke2, Rosebud O Roberts2, Val J Lowe3, Mary M Machulda4, Walter K Kremers2, Yonas E Geda5, Clifford R Jack3.   

Abstract

Despite much attention to the use of biomarkers for predicting Alzheimer disease, little information is available at the individual level. We used the population-based Mayo Clinic Study of Aging to estimate absolute risk of cognitive impairment by biomarker group. Risk increased with age and any biomarker abnormality. For example, a 75-year-old with abnormal amyloid and cortical thinning biomarkers has about a 20% chance of cognitive impairment by age 80 years, whereas with normal biomarkers the chance is <10%. Persons with only one abnormal biomarker had similar intermediate risks. ANN NEUROL 2019;85:155-160.
© 2018 American Neurological Association.

Entities:  

Mesh：

Year:  2019        PMID： 30521086      PMCID： PMC6504922          DOI： 10.1002/ana.25388

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  20 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 4.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

5.  Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.

Authors:  David A Wolk; Carl Sadowsky; Beth Safirstein; Juha O Rinne; Ranjan Duara; Richard Perry; Marc Agronin; Jose Gamez; Jiong Shi; Adrian Ivanoiu; Lennart Minthon; Zuzana Walker; Steen Hasselbalch; Clive Holmes; Marwan Sabbagh; Marilyn Albert; Adam Fleisher; Paul Loughlin; Eric Triau; Kirk Frey; Peter Høgh; Andrea Bozoki; Roger Bullock; Eric Salmon; Gillian Farrar; Christopher J Buckley; Michelle Zanette; Paul F Sherwin; Andrea Cherubini; Fraser Inglis
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

6.  Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Authors:  Rosebud O Roberts; David S Knopman; Jeremy A Syrjanen; Jeremiah A Aakre; Maria Vassilaki; Walter K Kremers; Michelle M Mielke; Mary M Machulda; Jonathan Graff-Radford; Yonas E Geda; Prashanthi Vemuri; Val Lowe; Clifford R Jack; Ronald C Petersen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

7.  Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.

Authors:  D S Knopman; C R Jack; H J Wiste; S D Weigand; P Vemuri; V Lowe; K Kantarci; J L Gunter; M L Senjem; R J Ivnik; R O Roberts; B F Boeve; R C Petersen
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.

Authors:  Rosebud O Roberts; Jeremiah A Aakre; Walter K Kremers; Maria Vassilaki; David S Knopman; Michelle M Mielke; Rabe Alhurani; Yonas E Geda; Mary M Machulda; Preciosa Coloma; Barbara Schauble; Val J Lowe; Clifford R Jack; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

10.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282
View more
  14 in total

1.  Age differences in the relationship between cortisol and emotional memory.

Authors:  Angela Gutchess; Alana N Alves; Laura E Paige; Nicolas Rohleder; Jutta M Wolf
Journal:  Psychol Aging       Date:  2019-06-10

2.  White matter hyperintensities: relationship to amyloid and tau burden.

Authors:  Jonathan Graff-Radford; Eider M Arenaza-Urquijo; David S Knopman; Christopher G Schwarz; Robert D Brown; Alejandro A Rabinstein; Jeffrey L Gunter; Matthew L Senjem; Scott A Przybelski; Timothy Lesnick; Chadwick Ward; Michelle M Mielke; Val J Lowe; Ronald C Petersen; Walter K Kremers; Kejal Kantarci; Clifford R Jack; Prashanthi Vemuri
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

3.  A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.

Authors:  Min Wang; Zhuangzhi Yan; Shu-Yun Xiao; Chuantao Zuo; Jiehui Jiang
Journal:  Behav Neurol       Date:  2020-08-18       Impact factor: 3.342

4.  Deep Learning Prediction of Mild Cognitive Impairment using Electronic Health Records.

Authors:  Sajjad Fouladvand; Michelle M Mielke; Maria Vassilaki; Jennifer St Sauver; Ronald C Petersen; Sunghwan Sohn
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2020-02-06

Review 5.  New insights into atypical Alzheimer's disease in the era of biomarkers.

Authors:  Jonathan Graff-Radford; Keir X X Yong; Liana G Apostolova; Femke H Bouwman; Maria Carrillo; Bradford C Dickerson; Gil D Rabinovici; Jonathan M Schott; David T Jones; Melissa E Murray
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

6.  Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice.

Authors:  Elena Puris; Štěpán Kouřil; Lukáš Najdekr; Sanna Loppi; Paula Korhonen; Katja M Kanninen; Tarja Malm; Jari Koistinaho; David Friedecký; Mikko Gynther
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

7.  Brain amyloid, cortical thickness, and changes in activities of daily living.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Walter K Kremers; Timothy G Lesnick; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Lesley Butler; Martin Traber; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Rosebud O Roberts; Ronald C Petersen
Journal:  Ann Clin Transl Neurol       Date:  2020-04-21       Impact factor: 4.511

Review 8.  Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition.

Authors:  Lenka Krajcovicova; Patricia Klobusiakova; Irena Rektorova
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

9.  Relationships Between Chronic Pain Stage, Cognition, Temporal Lobe Cortex, and Sociodemographic Variables.

Authors:  Jared J Tanner; Shivani Hanchate; Catherine C Price; Cynthia Garvan; Song Lai; Roland Staud; Hrishikesh Deshpande; Georg Deutsch; Burel R Goodin; Roger B Fillingim; Kimberly T Sibille
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.

Authors:  Laura Xicota; Farid Ichou; François-Xavier Lejeune; Benoit Colsch; Arthur Tenenhaus; Inka Leroy; Gaëlle Fontaine; Marie Lhomme; Hugo Bertin; Marie-Odile Habert; Stéphane Epelbaum; Bruno Dubois; Fanny Mochel; Marie-Claude Potier
Journal:  EBioMedicine       Date:  2019-09-03       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.